Ticagrelor - Revision history

Danbot: Switch SMW query from broadtable to table format for better layout with TOC

2026-03-20T21:58:22Z

Switch SMW query from broadtable to table format for better layout with TOC

← Older revision		Revision as of 21:58, 20 March 2026
Line 76:		Line 76:
	\|?Has Route=Route		\|?Has Route=Route
	\|?Has Population=Population		\|?Has Population=Population
	\|format=~~broadtable~~		\|format=table
	\|headers=plain		\|headers=plain
	\|mainlabel=-		\|mainlabel=-

Danbot: Fix SMW query: replace link=subject with mainlabel=- to fix broken subobject fragment links

2026-03-20T17:25:51Z

Fix SMW query: replace link=subject with mainlabel=- to fix broken subobject fragment links

← Older revision		Revision as of 17:25, 20 March 2026
Line 78:		Line 78:
	\|format=broadtable		\|format=broadtable
	\|headers=plain		\|headers=plain
	\|~~link~~=~~subject~~		\|mainlabel=-
	\|sort=Has Indication		\|sort=Has Indication
	\|limit=50		\|limit=50

Danbot: Add dynamic SMW Indications by Condition table (auto-populated from disease pages via MedicationDose template)

2026-03-20T16:44:01Z

Add dynamic SMW Indications by Condition table (auto-populated from disease pages via MedicationDose template)

@@ Line 65: / Line 65: @@
 *Excretion: 26% excreted in urine (less than 1% as ticagrelor and the active metabolite); 58% excreted in feces
 *Mechanism of Action: Reversibly binds to the P2Y 12 class of adenosine diphosphate (ADP) receptors on platelets to prevent signal transduction and platelet activation
 ==See Also==

Elcatracho: /* See Also */

2021-03-06T02:49:38Z

Wgalvin85: /* References */ added

2019-04-02T18:15:13Z

References: added

← Older revision		Revision as of 18:15, 2 April 2019
Line 73:		Line 73:

	[[Category:Pharmacology]]		[[Category:Pharmacology]]
			Ticagrelor: Drug information. UpToDate. www.uptodate.com. Accessed April 2, 2019.

Wgalvin85: /* Special Populations */ added

2019-04-02T18:14:30Z

Special Populations: added

← Older revision		Revision as of 18:14, 2 April 2019
Line 18:		Line 18:
	*Renal Dosing		*Renal Dosing
	**Adult		**Adult
			*** No adjustment necessary
	**Pediatric		**Pediatric
	*Hepatic Dosing		*Hepatic Dosing
	**Adult		**Adult
			*** Mild impairment - no adjustment necessary
			*** Moderate impairment - not defined but use caution as undergoes hepatic metabolism
			*** Severe impairment - avoid use
	**Pediatric		**Pediatric

Ostermayer: Text replacement - "Hypotension " to "Hypotension"

2017-03-10T09:10:29Z

Text replacement - "Hypotension " to "Hypotension"

← Older revision		Revision as of 09:10, 10 March 2017
Line 42:		Line 42:
	**Hypertension (4%)		**Hypertension (4%)
	**[[Chest pain]]		**[[Chest pain]]
	**Hypotension (3%)		**[[Hypotension]](3%)
	*CNS		*CNS
	**Headache (7%)		**Headache (7%)

Rossdonaldson1: Text replacement - "Chest pain" to "Chest pain"

2016-09-25T21:49:58Z

Text replacement - "*Chest pain" to "*Chest pain"

← Older revision		Revision as of 21:49, 25 September 2016
Line 41:		Line 41:
	**Atrial fibrillation		**Atrial fibrillation
	**Hypertension (4%)		**Hypertension (4%)
	**Chest pain		**[[Chest pain]]
	**Hypotension (3%)		**Hypotension (3%)
	*CNS		*CNS

Rossdonaldson1: Text replacement - "Diarrhea" to "Diarrhea"

2016-09-24T15:26:22Z

Text replacement - "*Diarrhea" to "*Diarrhea"

← Older revision		Revision as of 15:26, 24 September 2016
Line 49:		Line 49:
	**Syncope/pre-syncope/loss of consciousness (2%)		**Syncope/pre-syncope/loss of consciousness (2%)
	*GI		*GI
	**Diarrhea, nausea (4%).		**[[Diarrhea]], nausea (4%).
	*Hematologic		*Hematologic
	**Non–CABG-related bleeding (9%)		**Non–CABG-related bleeding (9%)

Neil.m.young: Text replacement - "0 mg" to "0mg"

2016-07-22T19:34:26Z

Text replacement - "0 mg" to "0mg"

← Older revision		Revision as of 19:34, 22 July 2016
Line 5:		Line 5:

	==Adult Dosing==		==Adult Dosing==
	*ACS: ~~180 mg~~ (two ~~90 mg~~ tablets) loading dose		*ACS: 180mg (two 90mg tablets) loading dose
	**PO vs OG vs NG (depending on mental status)		**PO vs OG vs NG (depending on mental status)
	*ACS patients who have received a loading dose of [[Clopidogrel]] may be started on Ticagrelor		*ACS patients who have received a loading dose of [[Clopidogrel]] may be started on Ticagrelor
	*Maintenance: ~~90 mg~~ twice daily		*Maintenance: 90mg twice daily

	==Pediatric Dosing==		==Pediatric Dosing==

← Older revision		Revision as of 02:49, 6 March 2021
Line 67:		Line 67:

	==See Also==		==See Also==
	[[Antiplatelet]]		*[[Antiplatelet medications]]
			*[[Antiplatelet agent reversal]]

	==References==		==References==